Literature DB >> 4425887

"Locked-in" syndrome: report of seven cases.

C H Hawkes.   

Abstract

Seven cases of the "locked-in" syndrome are described. This is a disorder in which a conscious, mute patient is completely paralysed apart from some form of eye movement, usually as a result of an infarct in the ventral pons. Such patients are often assumed to be in coma and as a result may be distressed by inappropriate conversation around the bedside.

Entities:  

Mesh:

Year:  1974        PMID: 4425887      PMCID: PMC1612444          DOI: 10.1136/bmj.4.5941.379

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

2.  Persistent vegetative state after brain damage. A syndrome in search of a name.

Authors:  B Jennett; F Plum
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  "Locked-in" state with bilateral midbrain infarcts.

Authors:  J S Karp; H I Hurtig
Journal:  Arch Neurol       Date:  1974-02

4.  Acute progressive ventral pontine disease in heroin abuse.

Authors:  J H Hall; H R Karp
Journal:  Neurology       Date:  1973-01       Impact factor: 9.910

5.  Seven cases of cerebromedullospinal disconnection: the "locked-in" syndrome.

Authors:  R E Nordgren; W R Markesbery; K Fukuda; A G Reeves
Journal:  Neurology       Date:  1971-11       Impact factor: 9.910

6.  Clinical and electroencephalographic manifestations of vascular lesions of the pons.

Authors:  T N Chase; L Moretti; A L Prensky
Journal:  Neurology       Date:  1968-04       Impact factor: 9.910

7.  Decerebrate rigidity with preservation of consciousness.

Authors:  J H Halsey; A W Downie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

  7 in total
  14 in total

1.  The locked in syndrome.

Authors:  J M Pearce
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

2.  Perioperative use of bispectral (BIS) monitor for a pressure ulcer patient with locked-in syndrome (LIS).

Authors:  Christine Yoo; Elizabeth A Ayello; Bryan Robins; Victor R Salamanca; Marc J Bloom; Patrick Linton; Harold Brem; Daniel K O'Neill
Journal:  Int Wound J       Date:  2014-10       Impact factor: 3.315

3.  Pontine metastasis with dissociated bilateral horizontal gaze paralysis.

Authors:  C Pierrot-Deseilligny; J Goasguen; F Chain; J Lapresle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

4.  Multimodal electrophysiological studies including motor evoked potentials in patients with locked-in syndrome: report of six patients.

Authors:  C Bassetti; J Mathis; C W Hess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Locked in syndrome with a favourable outcome.

Authors:  P Landrieu; C Fromentin; M Tardieu; A Menget; P Laget
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

6.  Residual sentience and cognitive death: ethical issues in brain death and the persistent vegetative state.

Authors:  M Ladanyi
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

7.  Vertebral artery occlusion and oral contraceptives.

Authors:  E Ask-Upmark; E R Bickerstaff
Journal:  Br Med J       Date:  1976-02-28

8.  Reflex vertical gaze and the medial longitudinal fasciculus.

Authors:  L R Jenkyn; G Margolis; A G Reeves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

9.  One-and-a-half syndrome in ischaemic locked-in state: a clinico-pathological study.

Authors:  J Bogousslavsky; J Miklossy; F Regli; J P Deruaz; P A Despland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

10.  Premonitory symptoms of stroke in evolution to the locked-in state.

Authors:  J Liu; S Tuhrim; J Weinberger; S K Song; P J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.